BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  BeyondSpring Announces First Quarter 2021 Financial Results and Provides a Corporate Update

  BeyondSpring today announced its financial results for the first quarter ended March 31, 2021 and provided an update on recent corporate events.

  June 16, 2021

   · 

  10 min read
• Motus GI Announces First Patients Enrolled in the European Union Feasibility Study of the Pure-Vu® System as a New Method for Bowel Cleansing in Patients With a History of Poor Bowel Preparation

  Motus GI Holdings, Inc. announced today enrollment of the first patients in the European Union (EU) study of the Pure-Vu System.

  June 16, 2021

   · 

  6 min read
• Biotech Bay

  89bio to Participate in Upcoming Investor Conferences

  89bio, Inc. today announced that Company’s Management will participate in the following upcoming investor conferences in June: SVB Leerink CybeRx Series: Liver Disease Day Format: One-on-one investor meetings Date: Thursday, June 17, 2021

  June 16, 2021

   · 

  1 min read
• Drug Development

  Aprea Therapeutics Announces Phase 1/2 Trial of Eprenetapopt + Venetoclax + Azacitidine in TP53 Mutant AML Meets Complete Remission Primary Efficacy Endpoint

  Aprea Therapeutics, Inc. today announced that the Phase 1/2 trial evaluating the frontline treatment of eprenetapopt with venetoclax and azacitidine in patients with TP53 mutant AML has met the pre-specified primary efficacy endpoint of complete remission rate.

  June 16, 2021

   · 

  6 min read
• BioCapital

  Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members

  Veralox Therapeutics today announced the closing of a $16.6 million Series A financing.

  June 16, 2021

   · 

  2 min read
• Biotech Beach

  Pancreatic Cancer Action Network Partners With FibroGen To Bring New Experimental Treatment Arm To Adaptive Clinical Trial, Precision Promise(SM)

  The Pancreatic Cancer Action Network (PanCAN), a leading pancreatic cancer advocacy organization, announced today the latest update to its novel clinical trial platform, Precision PromiseSM, with the addition of a new treatment arm by biopharmaceutical company, FibroGen, Inc.

  June 16, 2021

   · 

  4 min read
• Lipocine To Present At The Raymond James Human Health Innovation Conference

  Lipocine Inc. today announced that the Company will present at the Raymond James Human Health Innovation Conference.

  June 16, 2021

   · 

  2 min read
• Biotech Beach

  ViaCyte to Present at the Raymond James 2021 Human Health Innovation Conference

  ViaCyte, Inc. announced today that Michael Yang , President & CEO, and Brittany Bradrick , CFO & COO, will present at the Raymond James 2021 Human Health Innovation Conference on Wednesday, June 23, 2021.

  June 16, 2021

   · 

  1 min read
• Biotech Beach

  GT Biopharma to Present at Raymond James Human Health Innovation Conference

  GT Biopharma, Inc. today announced that it will provide a corporate update at the upcoming Raymond James Human Health Innovation Conference on Tuesday, June 22, 2021 at 11:20 AM ET.

  June 16, 2021

   · 

  1 min read
• Business

  INSPIRA-Technologies Announces New Medical Advisory Board Member - Dr. Avraham Abutbul - Specialist in Internal Medicine, General Intensive Care Medicine and Pulmonary Medicine

  INSPIRA Technologies Ltd., a leader in breakthrough respiratory medical technology, announced that Avraham Abutbul, MD, head of Hadassah Medical Center for COPD, has joined the clinical advisory board of INSPIRA-Technologies.

  June 16, 2021

   · 

  2 min read